SCHEMBL17035102

SCHEMBL17035102

c1ccc(-c2nc3ccccc3c3c2ccc2c(-c4cc(-c5cccnc5)cc(-c5nc(-c6ccc7ccccc7c6)nc(-c6ccc7ccccc7c6)n5)c4)cccc23)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 4/20 0.46
CYP11B2 P19099 4/20 0.46
CYP19A1 P11511 2/20 0.46
CYP17A1 P05093 2/20 0.46
GBA1 P04062 1/20 0.41
RAB9A P51151 2/20 0.39
NPC1 O15118 1/20 0.39
MAPT P10636 2/20 0.39
POLB P06746 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
CYP2A6 P11509 1/20 0.39
USP1 O94782 2/20 0.38
WDR48 Q8TAF3 2/20 0.38
CYP2C9 P11712 3/20 0.37
CYP1A2 P05177 3/20 0.37
CYP3A4 P08684 3/20 0.37
CLK4 Q9HAZ1 3/20 0.37
ALDH1A1 P00352 3/20 0.37
CYP2D6 P10635 2/20 0.37
TSHR P16473 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17035009 0.92 CYP11B1 (0.48) CYP11B1CYP11B2CYP19A1CYP17A1GBA1
SCHEMBL17035095 0.92 CYP1A2 (0.44) CYP11B1GBA1MAPTPOLBNPSR1
SCHEMBL17035183 0.91 MEN1 (0.40) MAPTCYP2C9CYP1A2CYP3A4CLK4
SCHEMBL17034935 0.90 CYP11B2 (0.50) CYP11B1CYP11B2CYP19A1CYP17A1GBA1
SCHEMBL17035100 0.89 MEN1 (0.43) CYP11B1CYP11B2CYP19A1CYP17A1GBA1
SCHEMBL17035074 0.88 CYP11B2 (0.51) CYP11B1CYP11B2CYP19A1CYP17A1GBA1
SCHEMBL17035099 0.88 MEN1 (0.43) MAPTCYP2C9CYP1A2CYP3A4CLK4
SCHEMBL17035097 0.85 MEN1 (0.46) MAPTCYP2C9CYP1A2CYP3A4CLK4
SCHEMBL19767318 0.85 MAPT (0.38) NPC1MAPTPOLBNPSR1CYP2C9
SCHEMBL17034933 0.85 ALDH1A1 (0.43) CYP11B1CYP11B2CYP19A1CYP17A1GBA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 CYP11B1 781/4885CYP11B2 857/4885CYP19A1 179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.